Citations

Clear

3138 citation(s) found for "Smith, AM".

Transesophageal Echocardiography in Patients With Magnetic Gastroesophageal Reflux Devices: A Report of 2 Cases
Malan, Shawn H. , Rehfeldt, Kent H., Alvord, Jeremy, Alvord, Jeremy M, Smith, Bradford B.

Mayo Clinic

A&A Practice | July 20, 2021 | Volume: 15 | Issue: 7 | Pages: e01497

10.1213/xaa.0000000000001497 | PMID 34283815 Get It

Magnetic gastroesophageal reflux devices are becoming a common treatment option for reflux refractory to medical therapy. These devices are inserted laparoscopically with successful outcomes; however, patients may still complain of dysphagia after implantation. Echocardiographers may be hesitant to perform transesophageal echocardiography (TEE) in these patients as esophageal surgery and dysphagia represent relative contraindications to performing TEE. However, we present 2 cases where intraoperative TEE was performed in patients with reflux devices without complication or image degradation. The described cases, in addition to a review of the perioperative management of these devices, support the use of TEE in this patient population.
Smoke-Free Policies and 30-Day Mortality Rates for Chronic Obstructive Pulmonary Disease
Hamadi, Hanadi , Stallings‐Smith, Sericea , Apatu, Emma , Peterson, Breck, Spaulding, Aaron , Spaulding, Aaron , Hamadi, Hanadi Y

Mayo Clinic

International Journal of Health Policy and Management | July 18, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.34172/ijhpm.2021.74 | PMID 34380194 Get It

Association Between Graft Choice and 6-Year Outcomes of Revision Anterior Cruciate Ligament Reconstruction in the MARS Cohort
Group, MARS, Wright, Rick W. , Huston, Laura J. , Haas, Amanda K. , Pennings, Jacquelyn S. , Cooper, Daniel E. , Dunn, Warren R. , Lantz, Brett A., Stuart, Michael J., Albright, John P., Amendola, Annunziato , Andrish, Jack T. , Annunziata, Christopher C., Arciero, Robert A. , Bach, Bernard R. , Baker, Champ L., Bartolozzi, Arthur R. , Baumgarten, Keith M. , Bechler, Jeffery R., Berg, Jeffrey H., Bernas, Geoffrey A., Brockmeier, Stephen F. , Brophy, Robert H. , Bush‐Joseph, Charles A., Butler, J. Brad, Campbell, John D. , Carey, James L. , Carpenter, James E. , Cole, Brian J. , Cooper, Jonathan M. , Cox, Charles L. , Creighton, R. Alexander , Dahm, Diane L., Flanigan, David C. , Frederick, Robert W., Ganley, Theodore J. , Garofoli, Elizabeth A. , Gatt, Charles J. , Gecha, Steven R., Hame, Sharon L. , Hannafin, Jo A., Harner, Christopher D. , Harris, Norman Lindsay, Hechtman, Keith S., Hershman, Elliott B., Hoellrich, Rudolf G., Johnson, David C. , Johnson, Timothy S. , Kaeding, Christopher C. , Kamath, Ganesh V. , Klootwyk, Thomas E., Levy, Bruce A. , Benjamin, C. , Maiers, G. Peter, Marx, Robert G. , Matava, Matthew J. , Mathien, Gregory M., McCarty, Eric C. , McCormack, Robert G. , Miller, Bruce S. , Nissen, Carl W. , O’Neill, Daniel F., Parker, Richard D., Purnell, Mark L., Ramappa, Arun J. , Rauh, Michael A. , Rettig, Arthur C., Sekiya, Jon K., Slauterbeck, James R., Smith, Matthew V. , Spang, Jeffrey T. , Svoboda, LTC Steven J., Taft, Timothy N., Tenuta, Joachim J., Tingstad, Edwin M., Vidal, Armando F. , Viskontas, Darius G., White, Richard A., Wolcott, Michelle L., Wolf, Brian R. , York, James J. , Svoboda, Steven J. , Brophy, Robert H. , McCarty, Eric C , Group, MARS, Allen, Christina R. , DeBerardino, Thomas M. , Spindler, Kurt P , Stuart, Michael J., Campbell, John D., David, Tal S. , Giffin, J. Robert , Johnson, David C., Jones, Morgan H. , McAllister, David R. , Owens, Brett D. , Shea, Kevin G. , Sherman, Orrin H. , Williams, James S.

Mayo Clinic

The American Journal of Sports Medicine | July 14, 2021 | Volume: 49 | Issue: 10 | Pages: 2589-2598

10.1177/03635465211027170 | PMID 34260326 Get It

Background: Although graft choice may be limited in the revision setting based on previously used grafts, most surgeons believe that graft choice for anterior cruciate ligament (ACL) reconstruction is an important factor related to outcome. Hypothesis: In the ACL revision setting, there would be no difference between autograft and allograft in rerupture rate and patient-reported outcomes (PROs) at 6-year follow-up. Study Design: Cohort study; Level of evidence, 2. Methods: Patients who had revision surgery were identified and prospectively enrolled in this cohort study by 83 surgeons over 52 sites. Data collected included baseline characteristics, surgical technique and pathology, and a series of validated PRO measures. Patients were followed up at 6 years and asked to complete the identical set of PRO instruments. Incidence of additional surgery and reoperation because of graft failure were also recorded. Multivariable regression models were used to determine the predictors (risk factors) of PROs, graft rerupture, and reoperation at 6 years after revision surgery. Results: A total of 1234 patients including 716 (58%) men were enrolled. A total of 325 (26%) underwent revision using a bone-patellar tendon-bone (BTB) autograft; 251 (20%), soft tissue autograft; 289 (23%), BTB allograft; 302 (25%), soft tissue allograft; and 67 (5%), other graft. Questionnaires and telephone follow-up for subsequent surgery information were obtained for 809 (66%) patients, while telephone follow-up was only obtained for an additional 128 patients for the total follow-up on 949 (77%) patients. Graft choice was a significant predictor of 6-year Marx Activity Rating Scale scores ( P = .024). Specifically, patients who received a BTB autograft for revision reconstruction had higher activity levels than did patients who received a BTB allograft (odds ratio [OR], 1.92; 95% CI, 1.25-2.94). Graft rerupture was reported in 5.8% (55/949) of patients by their 6-year follow-up: 3.5% (16/455) of patients with autografts and 8.4% (37/441) of patients with allografts. Use of a BTB autograft for revision resulted in patients being 4.2 times less likely to sustain a subsequent graft rupture than if a BTB allograft were utilized ( P = .011; 95% CI, 1.56-11.27). No significant differences were found in graft rerupture rates between BTB autograft and soft tissue autografts ( P = .87) or between BTB autografts and soft tissue allografts ( P = .36). Use of an autograft was found to be a significant predictor of having fewer reoperations within 6 years compared with using an allograft ( P = .010; OR, 0.56; 95% CI, 0.36-0.87). Conclusion: BTB and soft tissue autografts had a decreased risk in graft rerupture compared with BTB allografts. BTB autografts were associated with higher activity level than were BTB allografts at 6 years after revision reconstruction. Surgeons and patients should consider this information when choosing a graft for revision ACL reconstruction.
Cost Conversations About Anticoagulation Between Patients With Atrial Fibrillation and Their Clinicians
Giblon, Rachel , Kunneman, Marlene, Lee, Alexander I., Hargraves, Ian , Sivly, Angela , Burnett, Bruce , Gorr, Haeshik, Roldan, Victor D. Torres , Spencer-Bonilla, Gabriella, Shah, Nilay D. , Brito, Juan P. , Investigators, Shared Decision Making for Atrial Fibrillation (SDM4AFib) Trial, Haffke, Alexander, Stier, Amy, Thota, Anjali, Simpson, Benjamin , Zeballos‐Palacios, Claudia , Vanmeter, Derek , Behnken, Emma , Ting, Henry H. , Anderson, Joel, Inselman, Jonathan , Muegge, Jule , Fleming, Kirsten, Olive, Marc, Vang, Miamoua, Ferrara, Michael J. , Wambua, Mike , Organick, Paige, Cabalka, Renee, Poplau, Sara , Abullarade, Carol, Keune, Shelly, Smith, Timothy D. , Barksdale, Bryan, Peters, Roma, Price, Memrie, Watson, Connie, Wolfe, Douglas A. , Haynes, Brian, Daniels, Paul R. , Jaeger, Thomas M. , Kamath, Celia C , Branda, Megan E. , Hargraves, Ian G, Sivly, Angela L, Torres Roldan, Victor D , Brito, Juan P , Kamath, Celia , Lee, Alexander I., Bellolio, Fernanda , Jackson, Elizabeth A. , Burnett, Bruce, Noseworthy, Peter A. , Montori, Víctor M. , Investigators, Shared Decision Making for Atrial Fibrillation (SDM4AFib) Trial, LeBlanc, Annie , Hess, Erik P. , Hamilton, James, Fleming, Kirsten, Linzer, Mark , Suzuki, Takeki , Harvey, Lisa Anne , Stephens, Shannon W. , Hickey, Theresa, Guyatt, Gordon , Tomlinson, George , Gersh, Bernard J. , McBane, Robert D.

Mayo Clinic

JAMA Network Open | July 13, 2021 | Volume: 4 | Issue: 7 | Pages: e2116009

10.1001/jamanetworkopen.2021.16009 | PMID 34255051 Get It

Acute Exercise Enhances The Ex Vivo Expansion And Cytolytic Phenotype Of Cytokine Induced Killer Cells
Gustafson, Michael P. , Zúñiga, Tiffany M. , Baker, Forrest L. , Smith, Kyle A. , Katsanis, Emmanuel , Simpson, Richard J.

Mayo Clinic

Medicine & Science in Sports & Exercise | July 12, 2021 | Volume: 53 | Issue: 8S | Pages: 366-366

10.1249/01.mss.0000763512.92841.7f Get It

Risk Prediction in Women With Congenital Long QT Syndrome
Bos, J. Martijn , Yoruk, Ayhan , Chen, Anita Y. , Lopes, Coeli M. , Huang, David T. , Kutyifa, Valentina , Aktaş, Mehmet K. , Rosero, Spencer , McNitt, Scott , Sotoodehnia, Nona , Kudenchuk, Peter J. , Arking, Dan E. , Briske, Kaylie A., Sorensen, Katrina B. , Ackerman, Michael J. , Zaręba, Wojciech , Sorensen, Katrina, J Ackerman, Michael, Bos, Johan M , Huang, David T , Zareba, Wojciech , Goldenberg, Ilan , Younis, Arwa , Rea, Thomas D. , Scott, Christopher G.

Mayo Clinic

Journal of the American Heart Association | July 9, 2021 | Volume: 10 | Issue: 14 | Pages: No page available

10.1161/jaha.121.021088 | PMID 34238014 Get It

Background We aimed to provide personalized risk estimates for cardiac events (CEs) and life‐threatening events in women with either type 1 or type 2 long QT. Methods and Results The prognostic model was derived from the Rochester Long QT Syndrome Registry, comprising 767 women with type 1 long QT (n=404) and type 2 long QT (n=363) from age 15 through 60 years. The risk prediction model included the following variables: genotype/mutation location, QTc‐specific thresholds, history of syncope, and β‐blocker therapy. A model was developed with the end point of CEs (syncope, aborted cardiac arrest, or long QT syndrome–related sudden cardiac death), and was applied with the end point of life‐threatening events (aborted cardiac arrest, sudden cardiac death, or appropriate defibrillator shocks). External validation was performed with data from the Mayo Clinic Genetic Heart Rhythm Clinic (N=467; type 1 long QT [n=286] and type 2 long QT [n=181]). The cumulative follow‐up duration among the 767 enrolled women was 22 243 patient‐years, during which 323 patients (42%) experienced ≥1 CE. Based on genotype‐phenotype data, we identified 3 risk groups with 10‐year projected rates of CEs ranging from 15%, 29%, to 51%. The corresponding 10‐year projected rates of life‐threatening events were 2%, 5%, and 14%. C statistics for the prediction model for the 2 respective end points were 0.68 (95% CI 0.65–0.71) and 0.71 (95% CI 0.66–0.76). Corresponding C statistics for the model in the external validation Mayo Clinic cohort were 0.65 (95% CI 0.60–0.70) and 0.77 (95% CI 0.70–0.84). Conclusions This is the first risk prediction model that provides absolute risk estimates for CEs and life‐threatening events in women with type 1 or type 2 long QT based on personalized genotype‐phenotype data. The projected risk estimates can be used to guide female‐specific management in long QT syndrome.
Clinical Course and Features of Seizures Associated With LGI1-Antibody Encephalitis
Smith, Kelsey M. , Liebo, Greta B. , Britton, Jeffrey W. , Liebo, Greta B , Flanagan, E P , Britton, Jeffrey W , Smith, Kelsey M , Dubey, Divyanshu , Flanagan, Eoin P.

Mayo Clinic

Neurology | July 7, 2021 | Volume: 97 | Issue: 11 | Pages: No page available

10.1212/wnl.0000000000012465 | PMID 34233939 Get It

Surgical Reduction of Spondylolisthesis During Lumbar Fusion
Barber, Joshua A, Smith, Caleb J. , Li, Jinpu , Goldstein, Christina L, Leary, Emily , Lambrechts, Mark James , Barber, Joshua A, Beckett, Nathan , Goldstein, Christina L, Cook, James L. , Choma, Theodore J.

Mayo Clinic

Clinical Spine Surgery | July 7, 2021 | Volume: 35 | Issue: 1 | Pages: E1-E6

10.1097/bsd.0000000000001230 | PMID 34232155 Get It

Study Design: This was a retrospective cohort study. Objective: The objective of this study was to quantify the rates of complication following surgical treatment for symptomatic degenerative and isthmic spondylolisthesis and to examine the association between slip reduction and complication rates. Summary of Background Data: It is unclear if the degree of spondylolisthesis reduction during lumbar spine fusion in adults influences the rate of surgical complications. Methods: This is a retrospective cohort study of 1-level and 2-level adult fusion patients with degenerative or isthmic spondylolisthesis. The degree of reduction and complications were calculated, and complication rates between those with and without reduction were compared. Results: The surgical reduction was improved by 1 Meyerding grade in 56.5% of the 140 patients included in this analysis. Of those patients, 60% had a grade 1 spondylolisthesis. In addition, 62.5% of grade 2 slips had an improvement by 1 grade. Surgical reduction during lumbar fusion did not result in a higher rate of complications compared with in situ fusion. Conclusions: During 1-level or 2-level lumbar fusion for degenerative or isthmic spondylolisthesis, a 1-grade reduction of the slip was achieved in 56% of patients in this retrospective case series. Reduction of the spondylolisthesis was not associated with a higher rate of complication when compared with in situ fusion. Level of Evidence: Level IV.
The impact of patient and partner personality traits on learning success for a cognitive rehabilitation intervention for patients with MCI
Khayoun, Renata, Devick, Katrina L. , Chandler, Melanie , Shandera‐Ochsner, Anne L., Wit, Liselotte De , Cuc, Andrea , Locke, Dona E.C. , Chandler, Melanie J, De Wit, Liselotte , Locke, Dona E C , Smith, Glenn E.

Mayo Clinic

Neuropsychological Rehabilitation | July 7, 2021 | Volume: 32 | Issue: 10 | Pages: 2483-2495

10.1080/09602011.2021.1948872 | PMID 34232113 Get It

Abstract T P191: Using Clinical Trial Data to Generate Causative Classification System (CCS) Ischemic Stroke Phenotypes for the NINDS Stroke Genetics Network (SiGN)
Smith, Sherita Chapman, Gamble, Dale M., Benavente, Oscar, Brown, Robert D. , Kittner, Steven J. , Ay, Hakan , Worrall, Bradford B. , McClure, Leslie A. , Meschia, James F.

Mayo Clinic

Stroke | July 3, 2021 | Volume: 46 | Issue: suppl_1 | Pages: No page available

10.1161/str.46.suppl_1.tp191 Get It

Background: Recruitment and phenotyping constitute major costs in stroke genetics research. Clinical trial datasets that include biological samples provide an opportunity to leverage richly phenotyped cases for genomic research. However, the heterogeneity of stroke and methodological differences across studies present challenges. We developed and validated a systematic method of mapping data abstracted from a multicenter randomized clinical trial to the inputs of the CCS stroke subtyping system for the SiGN study. Methods: The SiGN Phenotype Committee and the Secondary Prevention of Small Subcortical Strokes (SPS3) research team systematically reviewed SPS3 case report forms (CRF) to identify key elements required to generate CCS subtyping, and drafted and refined mapping rules using a derivation set of 30 charts. The resultant algorithm was compared to manual entry of clinical information into the CCS in a test set of 30 randomly selected charts. This identified problems due to multiple versions of CRFs (up to 7 versions) and prompted revision of the mapping rules. We assessed the revised algorithm in an independent test set. Results: None of the subtype classifications agreed in the initial testing prompting revision to allow capture information from different versions of the CRFs. The revised mapping algorithm applied to the same test set performed well; 29/30 agreed - 20 small artery occlusion (SAO) evident, 4 SAO possible, 2 SAO probable and 3 supra-aortic large artery atherosclerosis evident). The one chart that disagreed was classified as SAO evident by manual entry but as undetermined by the data mapping rules. In the 2nd independent test set, 30/30 agreed: 22 SAO evident, 4 SAO possible, 3 supra-aortic large artery atherosclerosis evident and 1 undetermined unknown - incomplete evaluation. Conclusions: We created mapping rules using CRFs from a clinical trial to allow reliable subtype classification using the CCS. Issues related to multiple iterations of CRFs presented challenges. Highly phenotyped stroke cases from clinical trials represent a cost-effective opportunity for genomic research.